• About
  • Interesting shortcuts
  • Programmes and Partnerships
    • Search
    • European Partnerships
    • EU-Programme-Call
  • Projects
    • Projects
  • Resources
    • Resources
  • www.decubber.com
    • Login
  • Programmes and Partnerships
  • EU-Programme-Call
  • Horizon 2020
  • H2020-EU.3. SOCIETAL CHALLENGES
  • H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
  • H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2)
  • H2020-EU.3.1.7.0. Cross-cutting call topics
  • H2020-JTI-IMI2-2015-05-two-stage

H2020-JTI-IMI2-2015-05-two-stage

Mapped projects (6)
  • IMI2-2015-05-01 Patient perspective elicitation on benefits and risks of medicinal products, from development through the entire life cycle, to inform the decision-making process by regulators and Health Technology Assessment bodie
    (1)
  • IMI2-2015-05-02 Diabetic Kidney Disease Biomarkers (DKD-BM)
    (1)
  • IMI2-2015-05-03 Inflammation and AD: modulating microglia function – focussing on TREM2 and CD33
    (1)
  • IMI2-2015-05-04 Understanding the role of amyloid imaging biomarkers in the current and future diagnosis and management of patients across the spectrum of cognitive impairment (from pre-dementia to dementia)
    (1)
  • IMI2-2015-05-05 Evolving models of patient engagement and access for earlier identification of Alzheimer’s disease: Phased expansion study
    (1)
  • IMI2-2015-05-06 From ApoE biology to validated Alzheimer’s disease targets
    (1)
Powered by Chris Decubber BV